Epicrispr Biotechnologies has completed enrolment and dose escalation in the first-in-human trial of EPI-321, an epigenetic CRISPR-based therapy for...
Last year, the CasĪ¦ family of CRISPR endonucleases (also know as Cas12j) was discovered as a highly compact CRISPR system in ancient giant phages. At...
To make CRISPR medicines available for patients with genetic diseases, size matters. In a seminal article published today in Molecular Cell,...
